Hannah Valantine

Director, CareDx, Inc.; Director, BridgeBio Pharma, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$5.7M

Companies

Latest trade

Jul 16, 2026

Companies

CareDx, Inc.Director −$1.3M BridgeBio Pharma, Inc.Director −$4.4M

Trades

CDNA Sold 28,779 shares at $36.14 · planned $1.0M Jul 16

BBIO Sold 2,196 shares at $68.57 · planned $0.2M Jun 23

BBIO Sold 2,808 shares at $68.00 · planned $0.2M Jun 22

CDNA Sold 12,103 shares at $23.11 · planned $0.3M Jun 15

BBIO Sold 8,671 shares at $72.00 · planned $0.6M Mar 10

BBIO Sold 25,484 shares at $67.41 · planned $1.7M Feb 27

BBIO Sold 25,484 shares at $66.07 $1.7M Nov 12

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.